The Pro47Ser variant of p53 exists in African-descent populations, and is associated with increased 29 cancer risk in humans and mice. This variant, hereafter S47, shows altered regulation of the cystine 30
Introduction 44
The p53 tumor suppressor protein serves as a master regulator of the cellular response to 45 intrinsic and extrinsic stress. Mutations in the TP53 gene occur in more than 50% of human 46 cancers, and this gene is well-known as the most frequently mutated gene in cancer (Hollstein et 47 al., 1991) . p53 works to suppress uncontrolled cellular growth and proliferation through various 48 pathways including apoptosis, senescence, cell cycle arrest and ferroptosis (Stockwell et al., 2017; 49 Vousden and Prives, 2009). More recently a role for p53 in the control of metabolism has emerged. 50
The metabolic functions of p53 include the regulation of mitochondrial function, autophagy, 51 cellular redox state, and the control of lipid and carbohydrate metabolism (Berkers et al., 2013; 52 7 However, we were unable to see any differences in the steady state levels of LC3B or the 136 autophagy adaptor protein p62 SQSTM1 in WT and S47 MEFs or tissues, either at steady state ( Figure  137 1 -figure supplement 1E and F) or following HBSS treatment to induce autophagy (Figure 1 -138 figure supplement 1F). Likewise, we failed to see differences in viability after HBSS treatment 139 ( Figure 1 -figure supplement 1G ), nor did we note differences in autophagic flux (conversion of 140 LC3-I to LC3-II when the lysosome is inhibited) in WT and S47 cells (Figure 1 -figure supplement  141 1H). These data indicate that while markers of mTOR activity are increased in S47 cells and 142 tissues, this does not appear to be accompanied by an inhibition of autophagy. 143 144
Enhanced mitochondrial function and glycolysis in S47 cells 145
To determine the functional consequences of the increased markers of mTOR activity in 146 S47 cells, we used a Seahorse BioAnalyzer to assess the oxygen consumption rate (OCR), as well 147 as basal and stressed glycolytic rate. Seahorse analyses revealed that S47 LCLs consistently show 148 increased OCR under stressed conditions (Figure 2A ). We also found that both human and mouse 149 S47 cells show increased basal and compensatory glycolysis, compared to WT cells ( Figure 2B  150 and C). We next sought to more carefully analyze the rates of metabolism in WT and S47 cells 151 by assessing glucose and glutamine consumption using a Yellow Springs Instrument (YSI) 152
Analyzer. We also performed metabolic flux analyses in WT and S47 cells using 13 C-labeled 153 glucose. Analysis of glucose and glutamine consumption in WT and S47 LCLs and MEFs using 154 the YSI Analyzer revealed that S47 cells show increased consumption of glucose and glutamine, 155 along with increased production of lactate and glutamate, compared to WT cells ( Figure 2D -E). 156
We found no evidence that S47 cells proliferate more quickly than WT cells, and if anything S47 157
LCLs proliferate somewhat less rapidly than WT counterparts (Jennis et al., 2016) , suggesting that 8 this increased consumption is being used for biomass instead of proliferation. Interestingly, we 159 also analyzed LCLs from individuals heterozygous for the S47 variant (S47/WT), as well as MEFs 160 from mice heterozygous for this variant, and we noted that these values were typically intermediate 161 between homozygous WT and S47 cells ( Figure 2D -E). Analysis of 13 C6-glucose tracing in WT 162 and S47 MEFs provided evidence for a higher flux of glucose carbon into the TCA cycle in S47 163 cells compared to WT cells, as evidenced by increased labeling of citrate and malate ( Figure 2F The differences in mTOR activity between WT and S47 cells led us to hypothesize that 173 mitochondrial function is altered in these cells, and further that they might respond distinctly to 174 mTOR inhibition, since mTOR is known to regulate mitochondrial metabolism (Morita et al., the premise that the increased mTOR activity in S47 cells renders their mitochondrial function and 181 oxygen consumption resistant to inhibition of mTOR. 182 183 mTOR regulates body mass and muscle regeneration (Laplante and Sabatini, 2012; Yoon, 184 2017) . We therefore assessed body weight and composition in age-matched male mice of WT and 185 S47 genotypes. We also tracked body weight with age of multiple male and female sibling 186 littermate mice of WT/WT, WT/S47 and S47/S47 genotypes in our colony. S47 mice showed 187 increased weight with time, compared to WT/WT and WT/S47 sibling littermates ( 4 -figure supplement 1B-D). We next analyzed WT and S47 mice using a comprehensive lab 191 animal monitoring system (CLAMS) over the course of 48 hours. In this analysis, S47 mice 192 showed reduced food intake, oxygen consumption and heat production, but at the same time 193 comparable locomotor activity ( Figure 4D -I). These data support the conclusion that S47 mice 194 possess enhanced metabolic efficiency (less food but equal activity). Before testing this further, 195 we sought to determine the underlying mechanism for increased mTOR activity in S47 cells and 196 mice. 197
198

Increased mTOR activity in S47 is due to increased mTOR-Rheb interaction 199
We were unable to find convincing evidence that the modest differences in gene expression 200 of mTOR negative regulators in S47 cells (Figure 1 -figure supplement 1A) accounted for the 201 differences in mTOR activity between WT and S47 cells. We previously found that S47 cells 202 accumulate iron due to their ferroptotic defect, but we were unable to find evidence that the iron 203 chelator deferoxamine reduced mTOR activity in S47 cells (K. Gnanapradeepan, unpublished 204 observations). Therefore we next analyzed a key regulator of mTOR activity, the small GTPase 205
Rheb, which binds to and activates mTOR (Long et al., 2005) . We monitored the mTOR-Rheb 206 association in WT and S47 MEFs using the technique of proximity ligation assay (PLA), which 207 quantitatively detects protein-protein interactions. These PLA experiments indicated that there 208 were consistently increased mTOR-Rheb complexes in S47 cells, compared to WT; this was true 209 in multiple replicates, in multiple MEF clones ( Figure 5A -B). One of the recently-identified 210 regulators of the mTOR-Rheb interaction is the cytosolic enzyme GAPDH, which binds to Rheb 211 and sequesters it from mTOR (Lee et al., 2009 ). Using PLA, we found that the GAPDH-Rheb 212 association is markedly increased in WT cells relative to S47 cells ( Figure 5A GAPDH is a multi-functional enzyme that is well-known to be sensitive to redox status 218 (Brandes et al., 2009; Chernorizov et al., 2010) . We hypothesized that the increased glutathione 219 (GSH) levels in S47 cells (Leu et al., 2019) might alter the redox state of GAPDH, and likewise 220 alter its ability to bind to Rheb. To assess and compare the redox state of GAPDH in WT and S47 221 cells, we employed cross-linking experiments using the cysteinyl cross-linking agent 222 bismaleimidohexane (BMH), which cross-links cysteine residues within 13Å by covalently 223 conjugating free (reduced) sulfhydryl groups (Green et al., 2001) . BMH was used to treat freshly 224 isolated lung and skeletal muscle lysates from WT and S47 mice, as well as lysates from 225 immortalized WT and S47 MEFs. Cysteinyl-crosslinked proteins were resolved on SDS-PAGE 226 gels, and compared to untreated extracts. We found consistent differences in GAPDH cross-227 linking patterns in S47 samples compared to WT, as evident by altered mobility on SDS-PAGE of 228 BMH-treated samples ( Figure 5C -E). These data suggest that free sulfhydryls are different in WT 229 and S47 cells and tissues, possibly due to the increased GSH in S47 cells. To test this premise 230 further we pre-treated WT and S47 MEFs with the compound diethylmaleate (DEM), which 231 decreases the level of reduced GSH in cells (Leu et al., 2019) . We found that pre-treatment of 232 cells with DEM restores the mobility of GAPDH in S47 cells to that evident in cells with WT p53 233 ( Figure 5E ). Likewise, we found that depleting excess GSH in cells using DEM or the compound 234 buthionine sulfoximine (BSO, which decreases glutathione synthesis) completely restores 235 GAPDH-Rheb complex formation, and mTOR-Rheb complex formation, in S47 cells to levels 236 equivalent to WT cells ( Figure 5F combined data support the conclusion that the increased GSH pool in S47 cells affects the status 242 of reactive cysteines in GAPDH, and the ability of this protein to bind and sequester Rheb, thereby 243 leading to increased Rheb-mTOR interaction and increased mTOR activity in S47 cells. 244 245
Improved treadmill performance of S47 mice 246
The CLAMs data supporting increased metabolic efficiency in S47 mice prompted us to 247 challenge WT and S47 mice to treadmill exercise with increasing intensity over time; during this 248 time course, oxygen consumption and serum metabolites were quantified. For this analysis we 249 studied eight age-matched male mice of each genotype during a 50 minute forced exercise at 250 increasing speed and slope. Consistent with our CLAMs experiment, S47 mice start with lower 251 basal VO2 and exhibit generally lower VO2 for the work being performed until they approach the 252 final, most strenuous point of the exercise where the VO2 values in WT and S47 converge ( Figure  253 6A-C). Analysis of serum metabolites and proteins before and after exercise revealed decreased 254 lactate dehydrogenase (LDH) levels in S47 mice, indicating less muscle damage in S47 mice 255 compared to WT ( Figure 6D ). There were no other differences in serum metabolites between WT 256 and S47 mice ( Figure 6 -figure supplement 1A). We also monitored the pre-run soleus and 257 gastrocnemius muscle from WT and S47 mice for the steady state level of proteins involved in 258 mitochondrial metabolism, but found no differences in the steady level of any of these proteins 259 ( Figure 6 -figure supplement 1B ). Finally, we tested WT and S47 males on a continuous, more 260 strenuous, treadmill run and found that three out of four WT mice failed to complete the run, while In this study, we show that cells and mice bearing the S47 variant of p53 have increased 266 mTOR activity, increased metabolic efficiency and increased mass. The animals also display signs 267 of superior fitness. The enhanced mTOR activity is due in part to the higher levels of GSH in S47 268 cells and tissues, which we previously reported (Leu et al., 2019) . The increased GSH results in 269 impaired ability of the redox sensitive protein GAPDH to bind to Rheb. This leads to greater 270 mTOR-Rheb binding, resulting in increased mTOR activity in S47 cells and tissues. Our data 271
indicate that, along with pH (Walton et al., 2018), cellular redox status can also regulate mTOR 272 13 activity, in a manner controlled by p53. We show that oxidative metabolism in S47 cells is less 273 sensitive to mTOR inhibitors, thus tying these two phenotypes together; this is not surprising, as a 274 link between mTOR and a number of cellular metabolic processes is well known (Morita et al., 275 2013; Schieke et al., 2006) . One caveat of this study is that we do not directly demonstrate that 276 the increased mTOR activity in S47 mice is causing their superior performance on treadmill 277 assays; however, heightened mTOR activity is well-known to lead to enhanced muscle recovery 278 after exercise (Song et al., 2017; Yoon, 2017) . 279
280
We see evidence for increased mTOR activity only in certain tissues of the S47 mouse, so 281 the impact of this genetic variant appears to be somewhat tissue restricted. At present we do not 282 know if this tissue specificity is due to differences in GSH level, or to altered mTOR-Rheb or 283 GAPDH-Rheb interactions in different tissues, or to other parameters. We also see evidence for 284 some unexpected findings regarding the increase in mTOR activity in S47 cells: given that mTOR activity in the muscle of S47 mice leads to the indicators of improved fitness that we see in these 300 mice (see model, Figure 6E ). We hypothesize that the more efficient metabolism and enhanced 301 fitness provided by the S47 variant may have once provided carriers with a bio-energetic advantage 302
in Sub-Saharan western Africa, where this variant is most common. For example, those carrying 303 the S47 SNP may have possessed superior athletic prowess and/or ability to withstand famine. 304
This metabolic advantage may explain the high frequency of this genetic variant in sub-Saharan 305
Africa, despite the fact that it predisposes individuals to cancer later in life. A selection for this 306 variant in Africa may also include an improved ability to withstand malaria infection: we recently 307 reported that the S47 variant alters the immune micro-environment in mice, and confers improved 308 response to the malaria toxin hemozoin (Singh et al., 2020) . Both of these activities may have 309 conferred selection pressure for this variant in Africa. 310
311
Our findings provide further support for the growing premise that some tumor suppressor 312 genetic variants may provide evolutionary selection benefit (Vicens and Posada, 2018). For 313 example, women who carry the BRCA1/2 mutation exhibit increased size and enhanced fertility 314 when compared to controls (Smith et al., 2012) . Similarly, people with Li Fraumeni syndrome 315 who inherit germline mutations in TP53, as well as mice with tumor-derived germline mutations 316 in Tp53, demonstrate increased fitness endurance (Wang et al., 2013) , but this is due to increased 317 mitochondrial content, which we do not see in S47 cells. A common genetic variant in TP53 at 318 codon 72, encoding proline at amino acid 72, confers increased longevity while conversely causing 319 increased cancer risk (Zhao et al., 2018) . In contrast, the arginine 72 variant of p53 induces 320 increased expression of LIF, which influences fecundity (Kang et al., 2009 ). The take home 321 message from all of these studies is that the diverse roles of tumor suppressor proteins like p53 in 322 metabolism, fertility and fitness may allow for positive selection for certain variants, even at the 323 expense of increased cancer risk. In mice, this increased cancer risk occurs quite late in life, well Rabbit or mouse secondary antibodies conjugated to horseradish peroxidase were used at a 362 1:10,000 dilution (Jackson Immunochemicals), followed by a 5-minute treatment with ECL 363 (Amersham, RPN2232). Protein levels were detected using autoradiography and densitometry 364 analysis of protein content was conducted using ImageJ software (NIH, Rockville, MD). 365 366 Immunohistochemistry 367
Tissues were harvested and fixed in formalin overnight at 4°C, followed by a wash with 1X PBS 368 and were then placed in 70% ethanol prior to paraffin embedding. The Wistar Institute 369
Histotechnology Facility performed the tissue embedding and sectioning. For the 370 immunohistochemistry (IHC) studies, paraffin embedded tissue sections were de-paraffinized in 371 xylene (Fisher, X5-SK4) and re-hydrated in ethanol (100%-95%-85%-75%) followed by distilled 372 water. Samples underwent antigen retrieval by steaming slides in 10 mM Citrate Buffer (pH 6). 373
Endogenous peroxidase activity was quenched with 3% hydrogen peroxide and slides were 374 incubated in blocking buffer (Vector Laboratories, S-2012) for 1 hr. The slides were incubated 375 with phospho-p70S6K1 (1:100, ThermoFisher Scientific, PA5-37733) or phospho-mTOR (1:100, 376
Cell Signaling, 2971) primary antibody overnight at 4°C. The following day, slides were washed 377 with PBS and incubated with HRP-conjugated secondary antibody for 30 mins. Antibody 378 complexes were detected using DAB chromogen (D5637). Light counterstaining was done with 379 hematoxylin. Slides were imaged using the Nikon 80i upright microscope and at least four fields 380 were taken per section. 381 382
Mitochondrial metabolism assays 383
The oxygen consumption rate (OCR) and glycolytic rate were determined using the Seahorse XF 384
MitoStress Assay and the Seahorse XF Glycolytic Rate Assay, respectively, according to the 385 manufacturer's protocol. Cells were plated one day prior to the assay, LCLs at 100,000 cells/well 386 and MEFs at 60,000 cells/well. LCLs were treated with 200 nM rapamycin for 24 hours prior to 387 running MitoStress Assay. To determine mitochondrial content, WT and S47 MEFs were 388 incubated with 500 nM of MitoTracker Green (ThermoFisher Scientific, M7514) for one hour at 389 37°C. Cells were then spun down, washed once with PBS, spun down and resuspended in PBS. 390
The FACSCelesta (BD Biosciences) was used to detect fluorescence and at least 10,000 events 391
were measured per sample. 392 393
Metabolite measurements 394
Media was collected after 24 hours after plating LCLs or MEFs, and the YSI-71000 Bioanalyzer 395 was used to determine glucose, glutamine, lactate and glutamate levels as previously described 396 Metabolites were extracted by adding a solution of methanol/acetonitrile/water (5:3:2) to the well. 400
Plates were incubated at 4 o C for 5 minutes on a rocker and then the extraction solution was 401 collected. The metabolite extract was cleared by centrifuging at 15,000 x g for 10 minutes at 4 o C. WT and S47 mice in a pure C57Bl/6 background are previously described (Jennis et al., 2016) . 457
All mouse studies were performed in accordance with the guidelines in the Guide for the Care and 458
Use of Laboratory Animals of the NIH and all protocols were approved by the Wistar Institute 459
Institutional Animal Care and Use Committee (IACUC). Mice were fed an ad libitum diet and 460 were housed in plastic cages with a 12-hour/12-hour light cycle at 22°C unless otherwise stated. 461
Fat and lean content were measured in live male mice at 6 weeks of age using nuclear magnetic 462 resonance (NMR) with the Minispec LF90 (Bruker Biospin, Billerica, MA). Indirect calorimetry 463 was conducted to assess metabolic capabilities in mice (Oxyman/Comprehensive Laboratory 464
Animal Monitoring System (CLAMS); Columbus Instruments). Six-week old mice were single 465 caged, provided with water and food ad libitum and allowed to acclimate to the cages for 2 days. 466
Oxygen consumption (VO2) and carbon dioxide production (VCO2) were recorded for 48 hours 467 using an air flow of 600 ml/min and temperature of 22°C. Respiratory exchange ratio (RER) is 468 calculated as VCO2/VO2 and heat (kcal/h) is calculated by 3.815 + 1.232*(RER). Photodetectors 469 were used to measure physical activity (Optovarimex System; Columbus Instruments). 470 471
Treadmill and serum metabolite studies 472
Mice were allowed to acclimate to the metabolic treadmill (Columbus Instruments) for 5 minutes 473 before beginning their runs. The treadmill was then set to 5m/min and speed increased by 5m/min 474 every 2 minutes until 20m/min was reached. Upon reaching 20 m/min, the incline was increased 475 by 5 degrees every 2 minutes until reaching a maximum of 25 degrees. Mice were allowed to run 476 at this maximum speed and incline until exhaustion, defined by the mice spending 10 continuous 477 seconds on the shock grid. Lactate (Nova Biomedical) and glucose (One Touch) measurements 478 22 were taken using test strips just prior to treadmill entry and immediately after exhaustion using 479 handheld meters. Tail blood was also taken prior to treadmill entry and immediately after 480 exhaustion and metabolites measured using the Vettest serum analyzer (Idexx Laboratories). Student's t-test. 617 (C) Whole cell lysates were extracted from WT and S47 liver, lung, heart and kidney followed by 618
Western Blot analysis for the proteins indicated. 619 (D) Whole cell lysates were extracted from 3 WT and 3 S47 mouse lungs and analyzed by Western 620 blot for the phospho-Akt and GAPDH (loading control). Light and dark exposures are shown. 621 (E) Whole cell lysates were extracted from WT and S47 mouse lung and skeletal tissue and were 622 subjected to Western blot analysis, probing for p62, LC3B and HSP90 (loading control). 623 (F) WT and S47 MEFs were treated with HBSS for 0, 2 and 6 hours and were subjected to Western 624 blot analysis for the indicated proteins. 625 (G) WT and S47 MEFs were treated with HBSS for indicated time points and were subjected to 626 viability analysis using Trypan Blue; n = 3, error bars indicate standard deviation. 627 (H) Autophagic flux was measured in WT and S47 MEFs treated pretreated with NH4Cl for 628 indicate time points, followed by HBSS treatment for 6 hours. Cell lysates were subjected to 629
Western blot analysis and immunoblotted for LC3B and GAPDH (loading control). and S47 mice and subjected to Western Blot analysis for the proteins indicated. 684 (C) WT and S47 mice were subjected to a 60 minute treadmill run. 
